Falk Heidenreich Selected Research

Falk Heidenreich Research Topics

2	COVID-19 04/2021 - 01/2021
2	Leukemia 01/2020 - 11/2016
2	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2019 - 05/2007
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2018 - 11/2016
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 11/2016 - 05/2007
1	Body Weight (Weight, Body) 01/2021
1	Opportunistic Infections (Opportunistic Infection) 01/2019
1	Cytomegalovirus Infections (Inclusion Disease) 01/2019
1	Neoplasms (Cancer) 02/2018
1	Wilms Tumor (Wilm's Tumor) 11/2016
1	Hyperglycemia 08/2011
1	Male Infertility (Male Sterility) 11/2009
1	Obesity 11/2009
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 11/2009

4	Proteins (Proteins, Gene)FDA Link 02/2018 - 11/2009
3	ProteomeIBA 02/2018 - 11/2009
2	Peptides (Polypeptides)IBA 01/2021 - 11/2009
1	CC ChemokinesIBA 04/2021
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2021
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2021
1	HLA-A Antigens (HLA-A)IBA 01/2021
1	plerixafor FDA Link 01/2021
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2019
1	EpitopesIBA 02/2018
1	Myeloblastin (Proteinase 3)IBA 11/2016
1	Hyaluronic Acid (Hyaluronan)IBA 11/2016
1	AntigensIBA 11/2016
1	AcidsIBA 11/2016
1	NucleophosminIBA 11/2016
1	SurvivinIBA 11/2016
1	FibromodulinIBA 11/2016
1	Sperm ProteinsIBA 11/2009
1	Alemtuzumab (Campath)FDA Link 05/2007

2	Stem Cell Transplantation 01/2019 - 11/2016
2	Hematopoietic Stem Cell Transplantation 11/2016 - 05/2007
1	Blood Component Removal (Apheresis) 01/2021
1	Donor Selection 01/2020
1	Transplantation 01/2019
1	Immunotherapy 02/2018
1	Therapeutics 11/2009